Terms ending in 2030
Every in-force patent on Abraxis Bioscience, LLC's record whose computed term ends in 2030, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,308,279 | Sparc Binding Scfvs In force · High confidence | Abraxis Bioscience, LLC | In force | High confidence | |
| US 9,314,537 | Sparc Binding Scfvs In force · High confidence | Abraxis Bioscience, LLC | In force | High confidence | |
| US 9,446,003 | Prion Free Nanoparticle Compositions and Methods of Making Thereof In force · High confidence | Abraxis Bioscience, LLC | In force | High confidence | |
| US 10,206,887 | Prion Free Nanoparticle Compositions and Methods of Making Thereof In force · High confidence | Abraxis Bioscience, LLC | In force | High confidence | |
| US 8,927,019 | Methods and Compositions for Treating Recurrent Cancer In force · High confidence | Abraxis Bioscience, LLC | In force | High confidence | |
| US 9,091,697 | Use of 2 Anti-Sparc Antibodies to Predict Response to Chemotherapy for Pancreatic Adenocarcinoma In force · High confidence | Abraxis Bioscience, LLC | In force | High confidence | |
| US 8,383,358 | Use of 2 Anti-Sparc Antibodies to Predict Response to Melanoma Chemotherapy In force · High confidence | Abraxis Bioscience, LLC | In force | High confidence | |
| US 8,809,507 | Sparc Binding Scfvs In force · High confidence | Abraxis Bioscience, LLC | In force | High confidence |
8 of 8 patents shown. Soonest term end first, then patent number.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.